TrialCardiovascular diabetology2019

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).

Sho Kinguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.